State Street Corp Tg Therapeutics, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 9,199,908 shares of TGTX stock, worth $284 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,199,908

Previous 9,094,158 1.16%

Holding current value

$284 Million

Previous $213 Million 30.18%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$21.31 - $35.09 $2.25 Million - $3.71 Million	105,750 Added 1.16%	9,199,908 $277 Million
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $41.3 Million - $60.6 Million	2,398,015 Added 35.81%	9,094,158 $213 Million
Q2 2024 Aug 14, 2024	SELL	$13.32 - $19.19 $14.7 Million - $21.1 Million	-1,100,436 Reduced 14.11%	6,696,143 $119 Million
Q1 2024 May 15, 2024	SELL	$13.02 - $21.3 $5.95 Million - $9.73 Million	-456,994 Reduced 5.54%	7,796,579 $119 Million
Q4 2023 Feb 14, 2024	SELL	$6.68 - $18.81 $10.4 Million - $29.4 Million	-1,564,049 Reduced 15.93%	8,253,573 $141 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $35 Million - $111 Million	4,189,436 Added 74.44%	9,817,622 $82.1 Million
Q2 2023 Aug 14, 2023	SELL	$15.48 - $35.0 $31.2 Million - $70.5 Million	-2,015,619 Reduced 26.37%	5,628,186 $140 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $28.4 Million - $53.6 Million	-2,771,356 Reduced 26.61%	7,643,805 $115 Million
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $6.69 Million - $15.8 Million	-1,335,239 Reduced 11.36%	10,415,161 $123 Million
Q3 2022 Nov 15, 2022	SELL	$4.57 - $8.4 $11.4 Million - $20.9 Million	-2,484,863 Reduced 17.46%	11,750,400 $69.6 Million
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $17.2 Million - $49.1 Million	4,606,679 Added 47.84%	14,235,263 $60.5 Million
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $29.7 Million - $77.8 Million	3,804,406 Added 65.32%	9,628,584 $91.6 Million
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $23.2 Million - $54.2 Million	1,527,426 Added 35.55%	5,824,178 $111 Million
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $14.9 Million - $27.7 Million	684,605 Added 18.95%	4,296,752 $143 Million
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $11.5 Million - $17.3 Million	352,866 Added 10.83%	3,612,147 $140 Million
Q1 2021 May 17, 2021	SELL	$41.61 - $54.3 $18.9 Million - $24.6 Million	-453,561 Reduced 12.22%	3,259,281 $157 Million
Q4 2020 Feb 16, 2021	SELL	$25.27 - $54.9 $10 Million - $21.8 Million	-396,277 Reduced 9.64%	3,712,842 $193 Million
Q3 2020 Nov 10, 2020	SELL	$18.49 - $27.24 $17 Million - $25 Million	-918,008 Reduced 18.26%	4,109,119 $110 Million
Q2 2020 Aug 14, 2020	BUY	$8.9 - $21.84 $13.6 Million - $33.5 Million	1,532,474 Added 43.85%	5,027,127 $97.9 Million
Q1 2020 May 11, 2020	BUY	$7.14 - $15.99 $25 Million - $55.9 Million	3,494,653 New	3,494,653 $34.4 Million

Others Institutions Holding TGTX

# of Institutions

371

Shares Held

85.5M

Call Options Held

3.78M

Put Options Held

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.49B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Tg Therapeutics, Inc. Transaction History